Opatanol

olopatadine hydrochloride · Novartis Europharm Limited

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Opatanol, covering 2026-01-22 to 2026-01-22. Get the full timeline:

Most recent: EMA Authorised: Opatanol (olopatadine hydrochloride) — Novartis Europharm Limited